Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Lifevantage (LFVN) EBITDA (2016 - 2026)

Lifevantage filings provide 16 years of EBITDA readings, the most recent being $17000.0 for Q4 2025.

  • On a quarterly basis, EBITDA fell 99.09% to $17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $8.1 million, a 19.68% increase, with the full-year FY2025 number at $10.5 million, up 342.74% from a year prior.
  • EBITDA hit $17000.0 in Q4 2025 for Lifevantage, down from $2.0 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $4.9 million in Q2 2021 to a low of -$2.0 million in Q2 2022.
  • Median EBITDA over the past 5 years was $1.1 million (2024), compared with a mean of $1.3 million.
  • Biggest five-year swings in EBITDA: plummeted 318.0% in 2022 and later skyrocketed 1068.91% in 2024.
  • Lifevantage's EBITDA stood at -$100000.0 in 2021, then plummeted by 318.0% to -$418000.0 in 2022, then skyrocketed by 53.83% to -$193000.0 in 2023, then skyrocketed by 1068.91% to $1.9 million in 2024, then plummeted by 99.09% to $17000.0 in 2025.
  • The last three reported values for EBITDA were $17000.0 (Q4 2025), $2.0 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.